Dr. Clark S. Tsai, MD

Dr. Tsai practices at Clark S Tsai MD-Eye Center in Concord, California.

Dr. Tsai's NPI, 1720096829, was assigned on August 4, 2006. Dr. Tsai graduated from Albert Einstein College of Medicine in 1988. Dr. Tsai holds California license G76192.

Dr. Tsai's primary practice is Clark S Tsai MD-Eye Center, at 2225 Port Chicago Hwy, Concord, CA 94520-2051. The practice phone is (925) 689-7744.

Dr. Tsai's primary practice is Clark S Tsai MD-Eye Center in Concord, California. Dr. Tsai is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is John Muir Health. Dmand AI also links Dr. Tsai to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Tsai is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Tsai's licenses on file in 3 states: California, Florida and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, glaucoma and glaucoma surgery among the conditions Dr. Tsai treats.

CMS data shows 12,665 Medicare services from Dr. Tsai across 34 procedure codes in 2024, for 1,002 Medicare patients. Medicare paid $921,335 for them.

CMS counts 1,002 Medicare patients who saw Dr. Tsai in 2024. The largest group is 65 to 74, with 409 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 75, with 55% women.

In 2024, Dr. Tsai wrote 7,502 Medicare Part D claims for 1,191 patients. 65% of them were for generic drugs. CMS names the drug for 7,371 of them, across 30 drugs with 11 or more claims each, at $487,041 in total drug cost. In 2023, CMS named 6,692 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Tsai for performance year 2024, reported individually. Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 196 procedures of cataract surgery by Dr. Tsai, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Tsai. The most frequent topics are Optic Disk, Glaucoma, Open-Angle and Image Processing, Computer-Assisted. Dr. Tsai has published most often in Ophthalmology. Dr. Tsai's most frequent co-authors are Kyle A. Parrow, MD and Talya H. Kupin, MD.

Dmand AI links Dr. Tsai to 2 clinical trials. Conditions studied include Conjunctivitis, Bacterial and Eye Infections, Bacterial. Shire sponsors the most, 2.

CMS Open Payments shows 101 general payments to Dr. Tsai from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. MacuLogix, Inc. paid the most, $1,696.

Dmand AI lists 2 awards for Dr. Tsai, most recently CMS Stage 1 EHR in 2013.

Dr. Tsai graduated from Albert Einstein College of Medicine in 1988. Dr. Tsai is a member of AAO.

Dr. Tsai is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.